Jump to content

Nisa Leung

Shí Wikipedia, njikotá édémédé nke onyobulạ
Nisa Leung
mmádu
ụdịekerenwanyị Dezie
ọrụ ọ na-arụventure capitalist, partner Dezie
so naAsia Summit 2022 Dezie

Nisa Leung (Chinese:梁颕宇or梁颖宇) bụ onye na-achụ ego na onye njikwa na Qiming Venture Partners . Akpọrọ ya aha na Forbes Midas List afọ ise na-esochi na 2019, 2020, 2021,2022 na 2023. [1] [2] [3] [4] [5] na Best Women Venture Capitalists nke Forbes China afọ atọ. [6] [7] [8] A kpọkwara Nisa otu n'ime ụmụ nwanyị kachasị ike na azụmaahịa na China site na Fortune China na 2022 na 2023. [9] A maara Nisa nke ọma dị ka onye na-ebute ego na ahụike China. [10] [11] [12] [13]

Agụmakwụkwọ

[dezie | dezie ebe o si]

Nisa nwetara nzere bachelọ nke sayensị na Mahadum Cornell wee were MBA gụsịrị akwụkwọ na Stanford Graduate School of Business na 2001.

Ọrụ

[dezie | dezie ebe o si]

Nisa malitere ọrụ ya na ntinye ego ahụike mgbe ọ chọpụtara na enweghi ọgwụgwọ ọgwụgwọ dị elu na China mgbe ezinụlọ ya na-achọ ọgwụgwọ maka nwanne nna ya dị anya, bụ onye a chọpụtara na ọ nwere ọrịa cancer imeju. [14] [15]

Tupu isonyere Qiming Venture Partners na 2006, o mebere Biomedic Holdings, nke nwere ọrụ na itinye ego na ngwaọrụ ahụike, ọgwụ na ọrụ nlekọta ahụike na China gụnyere Novamed Pharmaceuticals (nke SciClone NASDAQ nwetara: SCLN) na U-Systems (enwetara. site na GE Healthcare). Ọ bụkwa onye mmekọ Venture nke PacRim Ventures na Menlo Park ma soro ya na Softbank/Mobius Venture Capital na mbụ. [16]

Na-eduga itinye ego nlekọta ahụike Qiming, Nisa akwadola ihe fọrọ nke nta ka ọ bụrụ ụlọ ọrụ nlekọta ahụike 200. [17] Ọ na-anọdụ ugbu a na bọọdụ Zai Lab (NASDAQ: ZLAB; HKSE: 9688), CanSino Biologics (SSE: 688185; HKSE: 6185), Caidya, Chain Medical Labs, Belief BioMed, Zencore Biologics, Valgen MedTech, Alamar Biosciences n'etiti ndị ọzọ. . Ntinye ego ya ndị ọzọ gụnyere Gan & Lee (SSE: 603087), New Horizon Health (HKSE: 6606), Berry Genomics (SZSE: 000710), CITIC Pharma (nke Shanghai Pharmaceutical HKSE nwetara: 2607), Crown Bioscience (nke JSR Life Sciences nwetara), Aeonmed Medical, Novast Pharmaceuticals, Nurotron, Origene Teknụzụ (nke VCAN Bio SSE nwetara: 600645), Richen, Vision Pro, MEDx, Cure Genetics, Goodwill (SSE: 688246), SinoCellTech (SSE: 688520), Sino Biological (SZSE: 3001) ), Apollomics (NASDAQ:APLM), SinoUnited Health, Schrödinger (NASDAQ: SDGR), Recursion (NASDAQ: RXRX), Insilico Medicine, Structure Therapeutics (NASDAQ: GPCR), Jacobio (HKSE: 1167), Hope Medicine, Sinotau, PlusLife n'etiti ndị ọzọ. [18]

Ntụaka

[dezie | dezie ebe o si]

akwadola ihe fọrọ nke nta ka ọ bụrụ ụlọ ọrụ nlekọta ahụike 200. [1] Ọ na-anọdụ ugbu a na bọọdụ

  1. ↑ No. 54 Nisa Leung (en). Forbes. Retrieved on 2023-04-19.
  2. ↑ Flannery. Mom's Encouragement Lands China Healthcare Investor On 2020 Forbes Midas List (en). Forbes. Retrieved on 2023-04-19.
  3. ↑ Standard. Qiming's Duane Kuang, Nisa Leung named on 2021 Forbes Midas List (en). The Standard. Retrieved on 2023-04-19.
  4. ↑ Nisa Leung (en). Forbes. Retrieved on 2023-04-19.
  5. ↑ The Midas List 2023 (en). Forbes. Retrieved on 2023-05-06.
  6. ↑ Forbes China. "福布斯中国2023女性创投人20揭晓：用敏锐、坚韧应对不确定性", Forbes China 福布斯中国, 2023-01-16.
  7. ↑ Forbes China. "福布斯中国发布2022年中国女性创投人20", Forbes China 福布斯中国, 2022-03-24.
  8. ↑ Forbes China (2023-04-19). 2018福布斯中国最佳女性创投人TOP25. Forbes China 福布斯中国.
  9. ↑ 梁颕宇 (zh-CN). 财富中文网. Retrieved on 2023-04-19.
  10. ↑ Wang. How China's Leading Female Healthcare Investor Backs Billion-Dollar Biotech Companies (en). Forbes. Retrieved on 2023-04-19.
  11. ↑ Ngui. "'Overinvested' China healthcare sector set for shake up, top venture fund says", Reuters, 2022-09-27. Retrieved on 2023-04-19. (in en)
  12. ↑ NISA LEUNG : Pioneering HK investor driven by improving lives and world-changing technologies (en-gb). www.hkstpnewsroom.com. Retrieved on 2023-04-19.
  13. ↑ Forbes China. "连续三年唯一上榜的中国医疗健康投资人，启明创投梁颕宇怎么看投资机会 | 全球最佳创投人榜", Forbes China 福布斯中国, 2021-04-15.
  14. ↑ Investing in China: It's Still "the Wild, Wild West" (en). Stanford Graduate School of Business (31 January 2023). Retrieved on 2023-04-19.
  15. ↑ Wang. How China's Leading Female Healthcare Investor Backs Billion-Dollar Biotech Companies (en). Forbes. Retrieved on 2023-04-19.
  16. ↑ Nisa Leung | Qiming Venture Partners. www.qimingvc.com. Retrieved on 2023-04-19.
  17. ↑ 【2023投资风向标】对话启明创投：医疗创新由点向面推进，重点关注跨界融合与效率提升_腾讯新闻. new.qq.com. Retrieved on 2023-04-19.
  18. ↑ Nisa Leung | Qiming Venture Partners. www.qimingvc.com. Retrieved on 2023-04-19.
Ewepụtara na https://ig.wikipedia.org/w/index.php?title=Nisa_Leung&oldid=190560